Plasmacytoid dendritic cells (pDC) are the most important cells to connect innate and adaptive immune responses, and also the main source of interferon (IFN)-a. IFN-a can suppress the activity of HBV enhancers, control HBV-posttranscriptional replication,,, and inhibit HBV nucleocapsid formation in virus replication. It can also limit virus infection by modulating both innate and adaptive immunity, directly activate natural killer (NK) cells to enhance their cytotoxicity to eliminate-infected cells, promote the maturation of DCs, stimulate naive cluster of differentiation antigen
8+ (CD8+) T cells, resulting in clonal expansion and proliferation, and increase expression of chemokines that recruit NK, T and B cells to the site of infection.
(1992) Extensive polymorphism in the extracellular domain of the mouse B cell differentiation differentiation antigen
Myeloid cell nuclear differentiation antigen
(MNDA) is a nuclear protein that mediates protein-protein interaction specifically with other transcription regulatory proteins.
Thymocyte differentiation antigen
1 (Thy-1 CD90) is used as a marker for a variety of mesenchymal stem cells .
Ber-MAC3: New monoclonal antibody that defines human monocyte/macrophage differentiation antigen
. J Clin Pathol 1991;44:936-945.
2C), CD99, smooth muscle antibody, and bcl-2, but not cytokeratin (Fig-2D), co-factor, epithelial membrane antigen, desmin, myogenic differentiation antigen
1, S-100, actin, or CD68.
The markers were derived during a series of Human Leukocyte Differentiation Antigen
NY-BR-1, a differentiation antigen
of the mammary gland, was first described in 2001 by Jager et al (134) using SEREX (a serologic analysis of recombinant tumor complementary deoxyribonucleic acid expression libraries) in a patient with breast cancer.
They reside in the skin and can be identified by the expression of the monocyte/macrophage and endothelial cell differentiation antigen
The CD14 monocyte differentiation antigen
maps to a region encoding growth factors and receptors.
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen
expression in metastatic melanoma.
Among the many melanoma antigens that have been identified so far, we chose to target the melanocytic differentiation antigen
Melan-A/MART-1 and the melanoma overexpressed antigen MELOE-1.